(Q47834312)

6 February 2018

title

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype. (English)

1 reference

6 February 2018

1 reference

1 reference

8

1 reference

6 February 2018

Francesca Ricci

object named as

Francesca Ricci

1

0 references

Monica Ganzinelli

object named as

Monica Ganzinelli

4

0 references

Massimo Broggini

object named as

Massimo Broggini

10

0 references

author name string

Sergio Bernasconi

2

1 reference

6 February 2018

Patrizia Perego

3

1 reference

6 February 2018

Giorgio Russo

5

1 reference

6 February 2018

Francesca Bono

6

1 reference

6 February 2018

Costantino Mangioni

7

1 reference

6 February 2018

Mario Signorelli

9

1 reference

6 February 2018

Giovanna Damia

11

1 reference

6 February 2018

publication date

15 May 2012

1 reference

6 February 2018

published in

Cell Cycle

1 reference

6 February 2018

volume

11

1 reference

6 February 2018

issue

10

1 reference

6 February 2018

page(s)

1966-1976

1 reference

6 February 2018

Management of borderline ovarian neoplasms

cites work

1 reference

Cancer stem cells: a step toward the cure.

21 January 2018

1 reference

Cancer stem cells: problems for therapy?

21 January 2018

1 reference

Cancer stem cells in solid tumors.

21 January 2018

1 reference

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

21 January 2018

1 reference

Tumor-initiating and -propagating cells: cells that we would like to identify and control

21 January 2018

1 reference

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

21 January 2018

1 reference

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

21 January 2018

1 reference

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

21 January 2018

1 reference

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

21 January 2018

1 reference

CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature

21 January 2018

1 reference

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.

21 January 2018

1 reference

Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy

21 January 2018

1 reference

Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance

21 January 2018

1 reference

Exploring the role of cancer stem cells in radioresistance

21 January 2018

1 reference

Cancer stem cells: a new framework for the design of tumor therapies.

21 January 2018

1 reference

The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth

21 January 2018

1 reference

Eradicating cancer cells: struggle with a chameleon

21 January 2018

1 reference

Epithelial-mesenchymal transition in cancer development and its clinical significance

21 January 2018

1 reference

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

21 January 2018

1 reference

Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma

21 January 2018

1 reference

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

21 January 2018

1 reference

Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Epithelial-mesenchymal transition and the stem cell phenotype.

21 January 2018

1 reference

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

21 January 2018

1 reference

ERCC5 is a novel biomarker of ovarian cancer prognosis

21 January 2018

1 reference

Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil.

21 January 2018

1 reference

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.

21 January 2018

1 reference

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

21 January 2018

1 reference

Role of Chk1 in the differentiation program of hematopoietic stem cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4161/CC.20308

1 reference

6 February 2018

PubMed ID

22544328

1 reference

6 February 2018